DAWN - Day One Biopharmaceuticals, Inc.
NEXT EARNINGS:
May 13, 2026
EPS Est: $-0.25
|
Rev Est: $54.6M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$26.00
DETAILS
HIGH:
$26.00
LOW:
$26.00
MEDIAN:
$26.00
CONSENSUS:
$26.00
UPSIDE:
116.31%
Market Cap:
1.23B
Volume:
2,046,150
Avg Volume:
2,550,603
52 Week Range:
5.635-13.2
Sector:
Healthcare
Industry:
Biotechnology
Beta:
-1.26
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
181
IPO Date:
2021-05-27
EPS (TTM):
-1.02
P/E Ratio:
N/A
Revenue (TTM):
131.16M
Total Assets:
582.79M
Total Debt:
2.60M
Cash & Equiv:
124.97M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-17.3%
Debt/Equity:
0.01
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-24 | $-0.21 | $-0.17 | -23.5% | $53.7M | $49.8M | +7.8% |
| 2025-11-04 | $-0.19 | $-0.28 | +31.8% | $39.8M | $38.2M | +4.2% |
| 2025-08-05 | $-0.29 | $-0.35 | +17.1% | $33.9M | $39.6M | -14.4% |
| 2025-05-06 | $-0.35 | $-0.46 | +23.9% | $30.8M | $36.5M | -15.8% |
| 2025-02-25 | $-0.69 | $-0.35 | -97.1% | $29.2M | $30.3M | -3.5% |
| 2024-10-30 | $0.38 | $-0.41 | +192.7% | $93.8M | $28.5M | +229.2% |
| 2024-07-30 | $-0.05 | $-0.67 | +92.5% | $8.2M | $1.0M | +698.2% |
| 2024-05-06 | $-0.72 | $-0.67 | -7.5% | — | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 131.16M | 0 | 0 | 0 | 0 | 0 |
| Net Income | (95.50M) | (188.92M) | (142.18M) | (70.64M) | (40.51M) | (12.63M) |
| EPS | -1.02 | -2.37 | -2.02 | -1.14 | -0.65 | -0.24 |
| Total Assets | 582.79M | 376.05M | 349.06M | 289.82M | 45.66M | 27.34M |
| Total Debt | 2.60M | 408,000 | 813,000 | 220,000 | 402,000 | 0 |
| Cash & Equivalents | 124.97M | 230.78M | 85.26M | 284.31M | 43.73M | 27.33M |
| Operating Cash Flow | (78.11M) | (146.85M) | (109.87M) | (48.54M) | (13.49M) | (4.51M) |
| Free Cash Flow | (80.28M) | (150.08M) | (109.90M) | (56.54M) | (13.58M) | (4.51M) |
| FCF per Share | -0.86 | -1.88 | -1.68 | -0.91 | -0.22 | -0.07 |
| Book Value | 502.75M | 346.54M | 332.04M | 281.15M | 37.76M | (10.67M) |
| Cash & ST Investments | 531.72M | 366.35M | 342.27M | 284.31M | 43.73M | 27.33M |
| ROC Equity | -0.19 | -0.55 | -0.43 | -0.25 | -1.07 | N/A |